✦ LIBER ✦

CD2-1 Efficacy and safety of sitagliptin or rosiglitazone when added to ongoing metformin therapy in patients with Type 2diabetes

✍ Scribed by Russell Scott; Tom Loeys; Michael J. Davies; Samuel S. Engel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of sitagliptin when

✍ R. Scott; T. Loeys; M. J. Davies; S. S. Engel; for the Sitagliptin Study 801 Gro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Efficacy and safety of sitagliptin added

✍ Raz, Itamar; Chen, Yu; Wu, Mei; Hussain, Shehla; Kaufman, Keith D.; Amatruda, Jo 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 671 KB

Efficacy and safety of sitagliptin when

✍ T. Vilsbøll; J. Rosenstock; H. Yki-Järvinen; W. T. Cefalu; Y. Chen; E. Luo; B. M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

Efficacy and Safety of the Dipeptidyl Pe

✍ Charbonnel, B.; Karasik, A.; Liu, J.; Wu, M.; Meininger, G. 📂 Article 📅 2006 🏛 American Diabetes Association 🌐 English ⚖ 148 KB

Efficacy and safety of the dipeptidyl pe

✍ Rhee, E. J.; Lee, W. Y.; Min, K. W.; Shivane, V. K.; Sosale, A. R.; Jang, H. C.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Efficacy and safety of monotherapy of si

✍ P. Aschner; H. L. Katzeff; H. Guo; S. Sunga; D. Williams-Herman; K. D. Kaufman; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB